Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma

NCT04570410 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma

Interventions

PROCEDURE: primary focal resection plus lymph node dissection
DRUG: Tislelizumab
DRUG: Gemcitabine plus cisplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University